Chemotherapy and Targeted Therapy for Endocrine-Pretreated or Hormone Receptor-Negative Metastatic Breast Cancer and Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: ASCO Guideline Rapid Recommendation Update Q and A

JCO oncology practice（2023）

引用 0|浏览7

暂无评分

摘要

5 med onc and path leaders help clinicians with HER2-low ADC decisions re patients, sequence, and AE.

查看译文

关键词

receptor–negative metastatic breast cancer,breast cancer,targeted chemotherapy,endocrine-pretreated

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要